The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes

被引:0
|
作者
Martina Brunner
Thomas Pieber
Stefan Korsatko
Harald Kojzar
Anne Louise Svendsen
Hanne Haahr
机构
[1] Medical University of Graz,Division of Endocrinology and Metabolism, Department of Internal Medicine
[2] Novo Nordisk A/S,Biostatistics
[3] Novo Nordisk A/S,Clinical Pharmacology
来源
Drugs & Aging | 2015年 / 32卷
关键词
Elderly Subject; Insulin Aspart; Pharmacodynamic Profile; Glucose Infusion Rate; Insulin Degludec;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:583 / 590
页数:7
相关论文
共 50 条
  • [1] The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults are Preserved in Elderly Subjects With Type 1 Diabetes
    Pieber, Thomas
    Korsatko, Stefan
    Deller, Sigrid
    Kojzar, Harald
    Roepstorff, Carsten
    Svendsen, Anne Louise
    Haahr, Hanne
    [J]. DIABETES, 2013, 62 : A237 - A237
  • [2] The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes
    Brunner, Martina
    Pieber, Thomas
    Korsatko, Stefan
    Kojzar, Harald
    Svendsen, Anne Louise
    Haahr, Hanne
    [J]. DRUGS & AGING, 2015, 32 (07) : 583 - 590
  • [3] Prandial and basal pharmacodynamic Properties of Insulin IDegAsp in young and elderly Subjects with Type 1 Diabetes are comparable
    Brunner, Martina
    Korsatko, Stefan
    Deller, Sigrid
    Kojzar, Harald
    Wolf, Michael
    Urschitz, Martina
    Roepstorff, Carsten
    Svendsen, Anne Louise
    Haahr, Hanne
    Pieber, Thomas R.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S19 - S19
  • [4] IDegAsp Shows Distinct Prandial and Basal Glucose-Lowering Effects at Steady State in Subjects With Type 1 Diabetes
    Heise, Tim
    Nosek, Leszek
    Hastrup, Hanne
    Chenji, Suresh
    Klein, Oliver
    Haahr, Hanne
    [J]. DIABETES, 2013, 62 : A235 - A235
  • [5] IDegAsp shows distinct prandial and basal glucose-lowering effects at steady state in subjects with type 1 diabetes
    Heise, T.
    Nosek, L.
    Hastrup, H.
    Chenji, S.
    Klein, O.
    Haahr, H.
    [J]. DIABETOLOGIA, 2013, 56 : S418 - S418
  • [6] Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus
    Tim Heise
    Leszek Nosek
    Carsten Roepstorff
    Suresh Chenji
    Oliver Klein
    Hanne Haahr
    [J]. Diabetes Therapy, 2014, 5 : 255 - 265
  • [7] Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus
    Heise, Tim
    Nosek, Leszek
    Roepstorff, Carsten
    Chenji, Suresh
    Klein, Oliver
    Haahr, Hanne
    [J]. DIABETES THERAPY, 2014, 5 (01) : 255 - 265
  • [8] Contributions of Basal and Prandial Hyperglycemia to Total Hyperglycemia in Older and Younger Adults with Type 2 Diabetes Mellitus
    Munshi, Medha N.
    Pandya, Naushira
    Umpierrez, Guillermo E.
    DiGenio, Andres
    Zhou, Rong
    Riddle, Matthew C.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (04) : 535 - 541
  • [9] Ultra-long pharmacokinetic properties of insulin degludec in younger adults are preserved in geriatric subjects with type 1 diabetes
    Korsatko, S.
    Deller, S.
    Mader, J.
    Glettler, K.
    Kohler, G.
    Bock, G.
    Urschitz, M.
    Wolf, M.
    Hastrup-Nielsen, H.
    Sondergaard, F.
    Haahr, H. L.
    Pieber, T. R.
    [J]. DIABETOLOGIA, 2012, 55 : S379 - S380
  • [10] Long-term effectiveness of insulin lispro in subjects with type 1 diabetes and basal-prandial regimen
    Hermans, MP
    Schmitt, H
    Buysschaert, M
    [J]. DIABETES, 2002, 51 : A472 - A472